Analysts Bullish on Top Healthcare Picks

By George MacDonald

There’s a lot to be optimistic about in the Healthcare sector as 2 experts just weighed in on EKSO BIONICS HOLDING (NASDAQ: EKSO) and Caladrius Biosciences Inc. (NASDAQ: CLBS) with bullish sentimens.

EKSO BIONICS HOLDING (NASDAQ: EKSO)

In a report issued on July 29, Amit Dayal from Rodman & Renshaw reiterated a Buy rating on EKSO BIONICS (NASDAQ: EKSO). The company’s shares closed last Friday at $6.19.

According to TipRanks.com, Dayal is ranked 0 out of 5 stars with an average return of -17.0% and a 33.3% success rate. Dayal covers the Technology sector, focusing on stocks such as Revolution Lighting Technologies, Ascent Solar Technologies, and Pointer Telocation Ltd.

EKSO BIONICS has an analyst consensus of Moderate Buy

.
Caladrius Biosciences Inc. (NASDAQ: CLBS)

In a report issued on July 28, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Caladrius Biosciences (NASDAQ: CLBS). The company’s shares closed last Friday at $5.54, close to its 52-week low of $4.01.

According to TipRanks.com, Selvaraju is a 1-star analyst with an average return of -1.2% and a 41.8% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as RegeneRx Biopharmaceuticals Inc, Biospecifics Technologies Corp, and Protalix Biotherapeutics.

Caladrius Biosciences has an analyst consensus of Moderate Buy

.